JPWO2025023183A1 - - Google Patents
Info
- Publication number
- JPWO2025023183A1 JPWO2025023183A1 JP2025535798A JP2025535798A JPWO2025023183A1 JP WO2025023183 A1 JPWO2025023183 A1 JP WO2025023183A1 JP 2025535798 A JP2025535798 A JP 2025535798A JP 2025535798 A JP2025535798 A JP 2025535798A JP WO2025023183 A1 JPWO2025023183 A1 JP WO2025023183A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023119284 | 2023-07-21 | ||
| PCT/JP2024/025989 WO2025023183A1 (ja) | 2023-07-21 | 2024-07-19 | 炎症性腸疾患を抑制する脂肪酸代謝産物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2025023183A1 true JPWO2025023183A1 (https=) | 2025-01-30 |
Family
ID=94374507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025535798A Pending JPWO2025023183A1 (https=) | 2023-07-21 | 2024-07-19 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2025023183A1 (https=) |
| WO (1) | WO2025023183A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1762557B1 (en) * | 2000-02-16 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Aspirin-triggered lipid mediators |
| WO2006106438A2 (en) * | 2005-01-11 | 2006-10-12 | Evolva Sa | Modulators of ppar activity |
| DK2858496T3 (da) * | 2012-05-10 | 2023-07-24 | Solutex Na Llc | Olier med anti-inflammatorisk aktivitet, som indeholder naturlige specialiserede pro-afhjælpningsmediatorer og deres forløbere |
| JP6604529B2 (ja) * | 2014-01-29 | 2019-11-13 | 岩手県 | ヒドロキシエイコサペンタエン酸の取得方法 |
| CN115887508A (zh) * | 2016-03-04 | 2023-04-04 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
| WO2021019037A1 (en) * | 2019-08-01 | 2021-02-04 | Evonik Operations Gmbh | Preparation comprising omega-3 fatty acid salts and extracts of gum resins from boswellia species |
| JP7589972B2 (ja) * | 2019-09-27 | 2024-11-26 | 国立大学法人 岡山大学 | 小胞型ヌクレオチドトランスポーター阻害剤 |
-
2024
- 2024-07-19 WO PCT/JP2024/025989 patent/WO2025023183A1/ja active Pending
- 2024-07-19 JP JP2025535798A patent/JPWO2025023183A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025023183A1 (ja) | 2025-01-30 |